openPR Logo
Press release

Wilms Tumor Treatment Market Projected to Reach US$ 2.2 Billion by 2031 with a CAGR of 4.7% - Leading Companies are Cepham Life Sciences, Pfizer Inc., Getwell Pharmaceuticals.

05-12-2025 01:44 PM CET | Health & Medicine

Press release from: DataM Intelligence 4market Research LLP

Wilms Tumor Treatment Market

Wilms Tumor Treatment Market

Wilms Tumor Treatment Market report, published by DataM Intelligence, delivers detailed insights and analysis on major market trends, growth prospects, and emerging challenges. With a strong focus on providing actionable intelligence, DataM Intelligence enables businesses to make well-informed decisions and maintain a competitive edge. By blending both qualitative and quantitative research approaches, the company offers thorough reports that support clients in navigating complex market environments, driving strategic expansion, and capitalizing on new opportunities in today's rapidly evolving global landscape.

Wilms Tumor Treatment Market reached US$ 1.5 billion in 2022 and is expected to reach US$ 2.2 billion by 2031 growing with a CAGR of 4.7% during the forecast period 2024-2031.

Request a Free Sample PDF of This Report (Corporate Email IDs Receive Priority Service): https://datamintelligence.com/download-sample/wilms-tumor-treatment-market?rk

Wilms tumor treatment refers to the medical strategies used to address Wilms tumor, a type of kidney cancer that primarily affects children. Treatment typically involves a combination of surgery to remove the affected kidney, chemotherapy to eliminate cancer cells, and sometimes radiation therapy, depending on the tumor's stage and characteristics. The approach aims to eradicate the cancer while preserving as much kidney function as possible. Early diagnosis and a tailored treatment plan significantly improve the prognosis for affected children.

The global Wilms tumor treatment market is experiencing significant growth, primarily driven by a rise in diagnoses of this pediatric kidney cancer. Wilms tumor typically develops in children, and according to the American Society of Clinical Oncology (ASCO) 2023 report, around 500-600 cases are diagnosed annually in the U.S. This tumor represents approximately 4% of all cancers diagnosed in children, further contributing to the market's expansion.

Wilms Tumor Treatment Market Recent Development:

On May 11, 2022, Cue Biopharma, Inc., a clinical-stage biopharmaceutical company focused on developing a new class of injectable biologics, announced that the U.S. FDA had approved its Investigational New Drug (IND) application. This approval allows the company to initiate a Phase 1 dose-escalation and expansion monotherapy trial of CUE-102-its second interleukin-2 (IL-2)-based biologic from the CUE-100 series starting at a dose of 1 mg/kg for the treatment of Wilms' tumor.

List of the Key Players in the Wilms Tumor Treatment Market:

Cepham Life Sciences, Pfizer Inc., Getwell Pharmaceuticals, Amneal Pharmaceuticals LLC, Medline Industries, LP., Sandoz International GmbH, Teva Canada Limited, Accord Healthcare Ireland Ltd., Eugia US LLC, Fresenius Kabi AG

Assessing the Effects of U.S. Tariffs on the Wilms Tumor Treatment Market

The U.S. tariff war is reshaping how businesses analyze trends and make strategic decisions. As tariffs drive up costs and disrupt supply chains, companies are increasingly focused on understanding consumer behavior, identifying new sourcing opportunities, and adjusting their operations to remain competitive. The ongoing uncertainty has created a stronger demand for timely insights and data-driven strategies to navigate shifting trade dynamics and economic pressures.

Research Process:

Both primary and secondary data sources have been used in the global Wilms Tumor Treatment Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/wilms-tumor-treatment-market?rk

Segment Covered in the Wilms Tumor Treatment Market:

By Type: Favorable Histology, Anaplastic Histology

By Treatment: Surgery, Chemotherapy, Radiation Therapy, Others

By End-users: Hospitals, Cancer Research Centers, Academic and Research Institutes

Regional Analysis for Wilms Tumor Treatment Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

People Also Ask:

Most Frequently Asked Questions in the Wilms Tumor Treatment Market Research Industry:

➠ What are the global figures for sales, production, consumption, imports, and exports in the Wilms Tumor Treatment market?

➠ Who are the top manufacturers in the global Wilms Tumor Treatment industry, and what is their current status in terms of production capacity, output, sales performance, pricing structure, cost analysis, profit margins, and overall revenue?

➠ What key opportunities are available for vendors in the Wilms Tumor Treatment market, and what challenges are they likely to encounter?

➠ Which application areas, end-user segments, or product types are projected to experience significant growth, and how is the market share distributed among them?

➠ What are the major drivers and barriers influencing the growth trajectory of the Wilms Tumor Treatment market?

➠ What are the primary sales, marketing, and distribution strategies used across the global Wilms Tumor Treatment industry landscape?

Browse More Reports: https://www.datamintelligence.com/research-report/wilms-tumor-treatment-market?rk

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Wilms Tumor Treatment Market Projected to Reach US$ 2.2 Billion by 2031 with a CAGR of 4.7% - Leading Companies are Cepham Life Sciences, Pfizer Inc., Getwell Pharmaceuticals. here

News-ID: 4010924 • Views:

More Releases from DataM Intelligence 4market Research LLP

United States Natural Astaxanthin Market to Reach USD 1.5 Billion by 2031, Growing at a CAGR of 7.7% | Rising Demand in Nutraceuticals and Aquaculture
United States Natural Astaxanthin Market to Reach USD 1.5 Billion by 2031, Growi …
Global Natural Astaxanthin Market reached US$ 0.84 billion in 2023 and is expected to reach US$ 1.5 billion by 2031, growing with a CAGR of 7.7% during the forecast period 2024-2031. The Natural Astaxanthin Market focuses on the use of astaxanthin, a powerful antioxidant derived from microalgae, in industries like food and beverages, pharmaceuticals, cosmetics, and nutraceuticals. Known for its health benefits, such as reducing inflammation and supporting skin health, the
Remote Browser Isolation Market reached US$ 0.59 billion in 2024 and is expected to reach US$ 5.35 billion by 2032 | Broadcom, Cisco, Cloudflare, ConnX
Remote Browser Isolation Market reached US$ 0.59 billion in 2024 and is expected …
Remote Browser Isolation Market reached US$ 0.59 billion in 2024 and is expected to reach US$ 5.35 billion by 2032, growing with a CAGR of 31.75% during the forecast period 2025-2032. Remote Browser Isolation (RBI) is a cybersecurity technology that separates a user's web browsing activity from their local network and endpoints by running the browser sessions on remote servers. This approach prevents malware, ransomware, and phishing attacks from reaching the
United States Liquid Chromatography Mass Spectrometry Market to Reach USD 19.10 Billion by 2032, Growing at a CAGR of 13.82% | Expanding Applications in Pharma, Biotech, and Food Safety
United States Liquid Chromatography Mass Spectrometry Market to Reach USD 19.10 …
The Liquid Chromatography Mass Spectrometry Market size reached US$ 6.78 billion in 2024 and is expected to reach US$ 19.10 billion by 2032, growing with a CAGR of 13.82% during the forecast period 2025-2032. LC-MS combines liquid chromatography and mass spectrometry for highly sensitive chemical, proteomic, and pharmaceutical analysis. Growth is driven by drug discovery, clinical diagnostics, and environmental testing. Applications include metabolomics, food safety, and biomarker identification. Research labs, pharmaceutical
United States Algae-Based Food Products Market Outlook 2024-2031: Rising Demand for Natural Proteins and Functional Nutrition | Top Companies are Cargill, Incorporated, AlgoSource E
United States Algae-Based Food Products Market Outlook 2024-2031: Rising Demand …
Global Algae-Based Food Products Market reached US$ 2.1 billion in 2023 and is expected to reach US$ 3.8 billion by 2031, growing with a CAGR of 7.69 % during the forecast period 2024-2031. The Algae-Based Food Products Market includes functional foods, beverages, and supplements made from spirulina, chlorella, and other algae. Growth is driven by health trends, vegan diets, and sustainability awareness. Products provide protein, omega-3s, antioxidants, and vitamins. Food manufacturers,

All 5 Releases


More Releases for Wilms

Wilms Tumor Market Emerging Trends and Growth Prospects 2034
Introduction Wilms tumor, or nephroblastoma, is a rare pediatric kidney cancer that typically affects children under the age of 5. Representing nearly 6% of all childhood cancers, Wilms tumor is one of the most treatable pediatric malignancies when diagnosed early. Advances in multimodal treatment approaches - surgery, chemotherapy, and radiotherapy - combined with emerging targeted therapies and genetic insights have significantly improved survival rates. The global Wilms Tumor Market is gaining momentum
Rising Incidence Of Kidney Cancers Drives Growth In The Wilms Tumor Protein Mark …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts Wilms Tumor Protein Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In recent times, the market size for the Wilms tumor protein has been experiencing consistent growth. It is projected to increase from $3.27 billion in 2024 to an estimated $3.42 billion in 2025, with
Key Trend Reshaping the Wilms Tumor Protein Market in 2025: Innovative Detection …
What Are the Projections for the Size and Growth Rate of the Wilms Tumor Protein Market? In the past few years, the wilms tumor protein market size has seen consistent growth. It is anticipated that it will increase from $3.27 billion in 2024 to $3.42 billion in 2025, with a compound annual growth rate (CAGR) of 4.7%. The growth during the historical period can be associated with the incidence and diagnosis
Wilms Tumor Treatment Market Analysis, Share, Trends, and Overview 2024-2031
The global Wilms tumor treatment market is anticipated to grow at a significant CAGR during the forecast period (2024-2031). Wilms tumor is a kind of kidney cancer that most commonly affects children. 'Nephroblastoma' is the name given to Wilms tumor. It usually affects youngsters between the ages of 3 and 4, however, in rare circumstances, it has been found in children as young as 5 years old. After the age
Wilms Tumor Protein Market Analysis 2024: Global Opportunities and Future Projec …
"The Business Research Company recently released a comprehensive report on the Global Wilms Tumor Protein Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The wilms tumor
Understanding Wilms Tumor Protein Market 2024
The wilms tumor protein market size has grown strongly in recent years. It will grow from $3.09 billion in 2023 to $3.27 billion in 2024 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to cancer incidence and diagnosis, rising awareness and screening programs, collaborations in cancer care.. The wilms tumor protein market size is expected to see strong growth